ProQR Therapeutics N.V. buy Oppenheimer Holdings Inc.
Start price
13.05.25
/
50%
€1.38
Target price
13.05.26
€8.10
Performance (%)
23.39%
Price
17.04.26
€1.62
Summary
This prediction is currently active. The prediction currently has a performance of 23.39%. This prediction currently runs until 13.05.26. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| ProQR Therapeutics N.V. | 3.918% | 3.918% |
| iShares Core DAX® | 3.593% | 3.931% |
| iShares Nasdaq 100 | 5.810% | 5.518% |
| iShares Nikkei 225® | 4.075% | 8.460% |
| iShares S&P 500 | 4.142% | 4.039% |
Comments by Oppenheimer_Holdings for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $15.00 to $9.00. They now have an "outperform" rating on the stock.
Ratings data for PRQR provided by MarketBeat
Stopped prediction by Oppenheimer_Holdings for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.51
12.03.26
12.03.26
€7.80
12.03.27
12.03.27
13.07%
17.04.26
17.04.26
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€2.36
10.01.25
10.01.25
€14.62
10.01.26
10.01.26
-37.64%
11.01.26
11.01.26